Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-2 mRNA expression in Tac-positive malignant lymphomas.

M Peuchmaur1, D Emilie, M C Crevon

  • 1INSERM U 131, Hôpital Antoine Béclère, Clamart, France.

The American Journal of Pathology
|February 1, 1990
PubMed
Summary

Interleukin-2 (IL-2) receptor expression is common in lymphomas. This study found IL-2 is produced by reactive T cells, suggesting a paracrine role in lymphoma growth, not autocrine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma.

Leukemia & lymphoma·2016
Same author

Enhanced glucocorticoid-induced leucine zipper in dendritic cells induces allergen-specific regulatory CD4(+) T-cells in respiratory allergies.

Allergy·2014
Same author

Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency.

Reproductive biomedicine online·2009
Same author

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Arthritis and rheumatism·2009
Same author

Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis.

Kidney international·2007
Same author

Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis.

Allergy·2007

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Malignant lymphomas often express the Interleukin-2 (IL-2) receptor (Tac antigen/CD25).
  • IL-2 is a critical lymphocyte growth factor, raising the possibility of IL-2-dependent lymphoma proliferation.
  • Previous studies demonstrated IL-2-dependent growth in experimental T-cell lines.

Purpose of the Study:

  • To investigate the role of IL-2 gene expression in human lymphomas.
  • To determine if IL-2 production contributes to the proliferation of Tac-positive lymphomas.
  • To differentiate between autocrine and paracrine IL-2 signaling in lymphoma growth.

Main Methods:

  • In situ hybridization was employed to detect IL-2 gene expression in lymphoma tissues.
  • Analysis included 20 non-Hodgkin's lymphomas, with a focus on 12 IL-2 receptor-positive cases.

Related Experiment Videos

  • Simultaneous detection of cellular antigens and IL-2 mRNA identified cell types producing IL-2.

    • Main Results:

    • IL-2-producing cells were identified in all analyzed lymphomas, regardless of Tac receptor expression.
    • The density of IL-2-producing cells varied significantly, with the highest observed in Tac-positive lymphomas.
    • IL-2 mRNA was predominantly found in reactive T cells, not in tumor cells.

    Conclusions:

    • IL-2 is produced by reactive T cells within the lymphoma microenvironment.
    • The findings suggest IL-2 acts as a paracrine factor, influencing lymphoma growth.
    • This challenges the concept of autocrine IL-2 signaling in Tac-positive lymphoma proliferation.